Valproic acid intoxication: Sense and non-sense of haemodialysis

Netherlands Journal of Medicine

Volumn 62, Issue 9, 2004, Pages 333-336

  Meek, M F ^a   Broekroelofs, J ^a   Yska, J P ^a   Egbers, P H M ^a   Boerma, E C ^a   van der Voort, P H J ^a  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; ALCOHOL; CARNITINE; MAGNESIUM SULFATE; OXYGEN; VALPROIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CASE REPORT; CONCENTRATION (PARAMETERS); DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INTOXICATION; EPILEPSY; FLUID THERAPY; GLASGOW COMA SCALE; HEMODIALYSIS; HUMAN; LIVER TOXICITY; MALE; MENTAL DISEASE; OXYGEN THERAPY; PLASMA PROTEIN BINDING; SUICIDE ATTEMPT; TREATMENT OUTCOME;

ADULT; EPILEPSY; ETHANOL; HEMODIAFILTRATION; HEMOPERFUSION; HUMANS; MALE; MENTAL DISORDERS; OVERDOSE; VALPROIC ACID;

EID: 6444235776     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Citrome L, Levine J, Allingham B. Utilization of valproate: extent of inpatient use in New York State Office of Mental Health. Psychiatr Q 1998;69:283-300.
2. Garnier R, Boudignat O, Fournier PE. Valproate poisoning. Lancet 1982;2:97.
3. Ware S, Milward-Sadler CH. Acute liver disease associated with sodium valproate. Lancet 1980;2:1110-3.
4. Wyllie E, Wyllie R, Cruse RP, Erenberg G, Rothner AD. Pancreatitis associated with valproic acid therapy. Am J Dis Child 1984;138:912-4
5. Tohen M, Castillo J, Baldessarini RJ, Zarate C Jr, Kando JC. Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk. Am J Psychiatry 1995;152:413-8.
6. Smith FR, Boots M. Sodium valproate and bone marrow suppression. Ann Neurol 1980;8:197-9.
7. Tank JE, Palmer BF. Simultaneous "in series" hemodialysis and hemoperfusion in the management of valproic acid overdose. Am J Kidney Dis 1993;22:341-4.
8. Pinkston R, Walker LA. Multiorgan system failure caused by valproic acid toxicity. Am J Emerg Med 1997;15:504-6.
9. Powell-Jackson PR, Tredger JM, Williams R. Hepatotoxicity to sodium valproate: a review. Gut 1984;25:673-81.
10. Chadwick DW, Cumming WJK, Livingstone I. Acute intoxication with sodium valproate. Ann Neurol 1978;6:552-3.
11. Turnbull DM. Adverse effects of valproate. Adverse Drug React Acute Poison Rev 1983;2:191-216.
12. Bowdle AT, Patel IH, Levy RH, Wilensky AJ. Valproic acid dosage and plasma protein binding and clearance. Clin Pharmacol Ther 1980;28:486-92.
13. Gugler R, Unruh GE von. Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet 1980;5:67-83.
14. Klotz U, Antonin KH. Pharmacokinetics and bioavailability of sodium valproate. Clin Pharmacol Ther 1977;21:736-43.
15. Ellenhorn MJ. Ellenhorn's Medical Toxicology. 2nd edition. Williams & Wilkins, Baltimore USA;1997:609-11.
16. Bregman H, Daugirdas JT, Ing TS. Complications during hemodialysis. In: Handbook of dialysis. 2nd ed. Daugirdas JT, Ing TS, editors. Little, Brown and Company; 1994:149-68.
17. Kane SL, Constantiner M, Staubus AE, Meinecke CD, Sedor JR. High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose. Ann Pharmacother 2000;34:1146-51.
18. Loiseau P, Bracket A, Henry P. Concentrations of dipropylacetate in plasma. Epiplesia 1974;16:609-15.
19. Bauer LA, Davis R, Wilensky A. Valproic acid clearance: unbound fraction and diurnal variation in young and elderly patients. Clin Pharmacol Ther 1985;32:697-700.
20. Bryson SM, Verma N, Scott PJW. Pharmacokinetics of valproic acid in young patients and elderly subjects. Br J Clin Pharmacol 1983;16:104-5.
21. Franssen EJ, Essen GG van, Portman AT, Jong J de, Co G, Stegeman CA, et al. Valproic acid toxicokinetics: serial hemodialysis and hemoperfusion. Ther Drug Monit 1999;21:289-92.
22. Dasgupta A, Crossey MJ. Elevated free fatty acid concentrations in lipemic sera reduce protein binding of valproic acid significantly more than phenytoin. Am J Med Sci 1997;313:75-9.
23. Smet R de, Kaer J van, Liebich H, Lesaffer G, Verstraete A, Dhondt A, et al. Heparin-induced release of protein-bound solutes during hemodialysis is an in vitro artifact. Clin Chem 2001;47:901-9.
24. Perucca E, Grimaldi R, Gatti G, Pirracchio S, Crema F, Frigo GM. Pharmacokinetics of valproic acid in the elderly. Br J Clin Pharmacol 1984;17:665-9.
25. Bauer LA, Davis R, Wilensky A, Raisys V, Levy RH. Valproic acid clearance: unbound fraction and diurnal variation in young and elderly adults. Clin Phamacol Ther 1985;37:697-700.